Indazolyl-substituted pyrroline compounds as kinase inhibitors
申请人:——
公开号:US20030055097A1
公开(公告)日:2003-03-20
The present invention is directed to novel indazolyl-substituted pyrroline compounds of Formula (I):
1
useful as kinase or dual-kinase inhibitors, methods for producing such compounds and methods for treating or ameliorating a kinase or dual-kinase mediated disorder.
INDAZOLYL-SUBSTITUTED PYRROLINE COMPOUNDS AS KINASE INHIBITORS
申请人:Ortho-McNeil Pharmaceutical, Inc.
公开号:EP1362047A2
公开(公告)日:2003-11-19
Substituted pyrrolines as kinase inhibitors
申请人:Zhang Han-Cheng
公开号:US20070213386A1
公开(公告)日:2007-09-13
The present invention is directed to novel substituted pyrroline compounds useful as kinase or dual-kinase inhibitors, methods for producing such compounds and methods for treating or ameliorating a kinase or dual-kinase mediated disorder.
SUBSTITUTED PYRROLINES AS KINASE INHIBITORS
申请人:Zhang Han-Cheng
公开号:US20100240650A1
公开(公告)日:2010-09-23
The present invention is directed to novel substituted pyrroline compounds useful as kinase or dual-kinase inhibitors, methods for producing such compounds and methods for treating or ameliorating a kinase or dual-kinase mediated disorder.